Inflammatory Bowel Disease

Gut dysbiosis is more frequent in patients with ankylosing spondylitis, compared with controls, and is associated with worse axial spondyloarthritis disease activity and physical function, according to data.

In this Healio video series, which focuses on cultural competency in the treatment of inflammatory bowel disease, Neilanjan Nandi, MD, FACP, discusses the importance of increasing community knowledge and destigmatizing IBD.

In this Healio video series, which focuses on cultural competency in the treatment of inflammatory bowel disease, Sharan Khela, an IBD patient advocate who has Crohn’s disease, shares her story and cultural stigmas she has had to overcome.

With a risk for COVID-19 similar to the general population, patients with inflammatory bowel disease should be receiving the “same exact treatment” as they did prior to the pandemic, according to a presenter at the GUILD Conference.

It is critical to consider all aspects of preventive care in patients with inflammatory bowel disease to avoid serious infections or complications, according to a presenter at GUILD 2022.

Skyrizi was effective and well tolerated during induction and maintenance therapy in patients with moderate to severe Crohn’s disease, according to two presentations at the Congress of the European Crohn’s and Colitis Organization.

The proteomic profile of breast milk of women with inflammatory bowel disease may affect an infant’s microbiome development and fecal calprotectin, according to a presenter at the Congress of the European Crohn’s and Colitis Organization.

Patients with Crohn’s disease who stopped infliximab had a significantly higher risk of relapse vs. those who continued combination therapy, according to results presented at the Congress of the European Crohn’s and Colitis Organization.

In this Healio video series, which focuses on cultural competency in the treatment of inflammatory bowel disease, Sumit Bhatia, MD, said many Indian patients do not accept diagnosis of the disease due to cultural stigmas.

Results from a new survey published in Inflammatory Bowel Diseases highlight the need for improved communication between physicians and patients regarding IBD treatment goals and expectations.